In the ongoing effort to combat mpox, it is critical to understand why it is now more important than ever to receive a second dose of the vaccine.
For individuals at risk of developing mpox (formerly known as monkeypox), getting two doses of the vaccine provides better protection than a single dose. As new cases emerge in the U.S., there is a risk of further spread. By ensuring timely vaccination of individuals susceptible to mpox, we can prevent resurgence and strengthen community-wide protection.
Why do I need a second dose?
according to public health insider, receiving a second dose of the vaccine provides the best protection. If you only had one dose of the JYNNEOS vaccine during last year’s outbreak, it’s not too late to catch up.
Notably, last year, many people were unable to get vaccinated due to supply shortages. This year, the mpox vaccine is in ample supply. Anyone seeking a vaccine or a second dose can get it without providing personal information or proving their level of risk. Vaccines were in short supply last year, so prioritizing exposure to individuals at highest risk.
Who should be vaccinated?
Public health officials recommend the mpox vaccine for:
- People who have had close or skin-to-skin contact with someone infected with mpox.
- A male or transgender person who has sex with a male or transgender person.
- Individuals involved in commercial and/or sexual transactions (for example, sex in exchange for money, housing, food, or other goods or needs).
- People who wish to be vaccinated can do so without disclosing personal risk information.
The mpox vaccine is not recommended for the general public who are not at risk of exposure to mpox. Vaccination is also not recommended for those already infected with mpox because past infection already provides protection against possible reinfection. However, those with significantly weakened immune systems can get vaccinated even if they have been infected before, Public Health Insider said.
Vaccine Efficiency
The Centers for Disease Control and Prevention (CDC) acknowledged last month that “no vaccine is 100% effective” after new cases were reported last year among people who had already received the JYNNEOS vaccine.
“More than 50% of cases reported in clusters have occurred in previously vaccinated populations. Vaccination is still important. No vaccine is 100% effective, and infection may occur after vaccination, but it may be milder and less likely to cause Hospitalized,” the CDC said.
Public health experts maintain that the mpox vaccine is effective in preventing infection, symptomatic illness, hospitalization and death. Studies have reportedly shown that two doses of the JYNNEOS vaccine are 66% to 88% effective in preventing infection. In addition, vaccinated individuals who did contract the virus tended to experience milder illness.
Published by Medicaldaily.com